Immunology and Microbiology
Dendritic Cell
80%
T Cell
70%
Antigen Presentation
49%
Immunity
40%
Cytotoxic T-Cell
39%
Tacrolimus
31%
Auranofin
31%
Precursor
31%
Immunotherapy
28%
Macrophage
23%
Programmed Death-Ligand 1
23%
Cytokine
23%
Autoimmunity
21%
Major Histocompatibility Complex
19%
Ciclosporin
18%
Immunosuppression
18%
Antigen Specificity
18%
Peptides
16%
Interleukin 27
15%
Lymphocyte Function
15%
Th9 Cell
15%
Mizoribine
15%
Gene Expression
15%
Achatina
15%
Regulatory T Cell
15%
Prostaglandin E2
15%
Allergic Airway Inflammation
15%
Cell Activity
15%
Nivolumab
15%
Sirolimus
15%
Interleukin 25
15%
T Cell Development
15%
Interferon
15%
Proinflammatory Cytokine
15%
TLR3
15%
Cyclooxygenase
15%
Th1 Cell
15%
Cytotoxic Lymphocyte
15%
T Helper Cell
15%
V Set Domain Containing T Cell Activation Inhibitor 1
15%
Dermatitis
15%
Macrophage Colony-Stimulating Factor
15%
Agonist
15%
TLR9
15%
Durvalumab
15%
Ipilimumab
15%
Keratinocyte
15%
Pathogenicity
15%
Epithelial Mesenchymal Transition
15%
Aloe vera
15%
Keyphrases
Dendritic Cells
100%
Antigen Presentation
66%
Ovalbumin
40%
Exogenous Antigen
39%
CD8+ T Cells
31%
Tacrolimus
31%
Auranofin
31%
T Cells
23%
MHC Class II
22%
Programmed Death-ligand 1 (PD-L1)
20%
Macrophages
20%
Major Histocompatibility Complex
19%
Cyclosporine
18%
Granulocyte Colony-stimulating Factor (G-CSF)
17%
Calcineurin Inhibitors
17%
B7 Family
17%
Co-inhibitory Molecules
17%
Tumor Microenvironment
17%
Overproduction
15%
Lymphocyte Function
15%
Inflammatory Cytokines
15%
MEK Inhibitor (MEKi)
15%
Baccatin III
15%
Antitumor
15%
Acharan Sulfate
15%
TLR3 Agonist
15%
Nivolumab
15%
Biodegradable Nanoparticles
15%
Trametinib
15%
Immune Checkpoint
15%
Tumor Growth
15%
Microsatellite Stable
15%
Tumor-associated Myeloid Cells
15%
Immunosuppressive Drugs
15%
Lung Cancer
15%
FOXO4
15%
B7-H3
15%
Mizoribine
15%
Metastatic Colorectal Cancer (mCRC)
15%
Nearest-neighbor Approach
15%
Shared Nearest Neighbor
15%
Phase II Study
15%
DKK3
15%
Monocytes
15%
Neoadjuvant Chemotherapy
15%
Cyclooxygenase-1 (COX-1)
15%
Hypoglycemic and Hypolipidemic Effect
15%
Th1 Cells
15%
Non-small Cell Lung Cancer (NSCLC)
15%
Salicornia Herbacea
15%
Medicine and Dentistry
T Cell
36%
Cytotoxic T-Cell
34%
Lung Cancer
31%
Aloe vera
31%
Dendritic Cell
28%
Immunocompetent Cell
22%
Immunotherapy
19%
Myeloid Cell
18%
Immunosuppressive Treatment
18%
Antigen Presenting Cell
18%
Programmed Death-Ligand 1
18%
Ovalbumin
18%
Tumor Microenvironment
17%
Immunity
16%
Nanosphere
15%
Cell Population
15%
Sulfate
15%
Hypolipemia
15%
V Set Domain Containing T Cell Activation Inhibitor 1
15%
Metastatic Colorectal Cancer
15%
Antidiabetic Agent
15%
Surgical Approach
15%
Neoplasm
15%
Mesenchymal-Epithelial Transition
15%
Snail
15%
Maturity Onset Diabetes of the Young
15%
Durvalumab
15%
Trametinib
15%
Cancer Surgery
15%
Major Histocompatibility Complex
14%
Peripheral Blood Mononuclear Cell
12%
Non Small Cell Lung Cancer
12%
Lung Adenocarcinoma
10%
Video-Assisted Thoracoscopic Surgery
9%
Galactosylceramide
8%
Adverse Event
7%
Lung Metastasis
7%
Liver Metastasis
7%
Tumor Cell
7%
Diseases
7%
Flow Cytometry
7%
Metastatic Carcinoma
6%
Immune Checkpoint Blockade
6%
Myeloid-Derived Suppressor Cell
6%
Surgical Stress
6%
Memory Cell
6%
Surgery
6%
Natural Killer Cell
6%
Thoracotomy
6%
Antineoplastic Activity
5%
